Hubungan Resistensi Insulin Menggunakan Homa-IR dengan Rasio Profil Lipid pada Penderita Sindroma Metabolik
60
DAFTAR PUSTAKA
Abboth, 2006. Glucose. Clinical Chemistry. Architec-Aeroseth. Abboth
Diagnostic. p 1-8
Abboth, 2006. Cholesterol. Clinical Chemistry. Architec-Aeroseth. Abboth
Diagnostic. p 1-12
Abboth, 2007. Triglyseride. Clinical Chemistry. Architec-Aeroseth. Abboth
Diagnostic. p 1-9
Abboth, 2008. UHDL. Clinical Chemistry. Architec-Aeroseth. Abboth
Diagnostic. p 1-9
Adekune,
A.E.
Akande,
Syndrome:Prevalence
A.O.
Adekunle,
A.O.
2014.
Metabolic
and Association with Electrocardiographic
Abnormalities in Nigerian Hypertensive Patients.Vol : 12(8) : 447 –
442.
Anwar, T.B. 2004. Dislipidemia sebagai factor resiko Penyakit Jantung
Koroner. Fakultas Kedokteran . e-Universitas Sumatera Utara. p.2.
Atkinson, R. 2004. Etiology of obesity : In The management of eating disorder
and obesity. Goldstein, J.D.ed. 2nd ed, New Jersey. Human Press Inc.
pp.105.
Ascaso, J.F. Pardo, S. Real, J.T. et.al. 2003. Diagnosis insulin resistance by
simple quantitative methods in subjects with normal glucose
metabolism. Diabetes care. 26 : 3320 – 3325.
Universitas Sumatera Utara
61
Aquilante,
C.L.
and
Griend
J.P.
V.2012.
Metabolic
syndrome.
Pharmacotherapy Self-Assessment Program. 6th Ed. 109 – 115.
Balai Penelitian dan Pengembangan Kesehatan , 2007. Depkes RI. Pedoman
Pengukuran dan Pemeriksaan. Riset Kesehatan Dasar.
Bakker, S.J. Gans, R. Maaten, J.C. 2001.The Potential Role of Adenosine in
The
Pathophysiology
of
The
Insulin
Resistance
Syndrome.
Atherosclerosis 2001. 156: 283 – 290.
Bosomworth, N.J.2013. Approach to identifying and managing atherogenic
dyslipidemia. Canadian Family Physician. Vol 59: 1169 -1180.
Brunzel, J.D. 2009. Genetic Dyslipidemia In : Clinical Lipidology .
Christie,M.ed. Saunders Elsevier. 1st ed. pp 71-80.
Byrne, C.D. 2005. The Global Burden of the Metabolic Syndrome and its
Consequencea for Diabetes and Cardiovascular. Dalam : Metabolic
Syndrome. England. Byrne, C.D. and Wild, S.W.ed. John Wiley & Sons
Ltd. pp. 1.
Byun, A.R. Wha S.L. Lee, H.S. Shim, K.W. 2015. What is the most
appropriate lipid profile ratio predictor for insulin resistance in each
sex? A cross sectional study in Korean populations (the fifth korea
national health and nutrition examination survey. Diabetology and
metabolic syndrome .7:59.
Universitas Sumatera Utara
62
Cerelio, A .2005. Oxidate stress, insulin resistance and cardiovascular
disease : In Metabolic Syndrome. Byrne, C.D. England : John Wiley &
Sons Ltd, pp. 191-190.
Chaves, A.G. Mendia, L.E.S. Argueta, S.E. 2011. Elevated triglycerides/HDL
cholesterol associated with insulin resistance. Cirugia y Cirujanos . 79
:115 – 119.
Cornier, M.A. Dabelea , D. Hernandez T.L. et.al. 2008. The metabolic
Syndrome : Endocrine Review. 29(7) :777 – 822.
Chu, M.A.2011. HOMA-IR and Its Association with Metabolic Risk Factors
among Korean Adolescent. Korean J Gastroenterolog Nutric.14(4):
376 -384
Davis, P.G. 2006. Lipid and lipoprotein metabolism. In : Lipid metabolism and
health. Moffat, R.J., Stamford, B. ed. United States of Taylor : Taylor &
Francis Group. p. 47-50.
Du, T.
Yuan,G. Zhang, M. et.al.2014. Clinical usefulness of lipid ratios,
visceral adiposity indicators, and the triglycerides and glucose index as
risk markers of insulin resistance. Cardiovascular Diabetology. :134.
p1-10.
Dupon, J.L. 2006. Basic Lipidogy In : Lipid Metabolism and Health. Moffatt,
J.R., Stamford, B. Taylor & Francis Group. United States of America.
p.13-17.
Universitas Sumatera Utara
63
Ezra, V.B.(2006)
Metabolic Syndrome In : Lipid metabolism and health.
Moffat, R.J., Stamford, B. ed. United States of Taylor : Taylor & Francis
Group. p. 47-50.
Gerich, J.E. Dodis, R. 2007. Glycemic control and the metabolic syndrome :
In Metabolic syndrome and cardiovascular, epidemiology, assesement
and management. Krentz, A.J.ed. United State of America. Informa
health care USA Inc, pp.145-155.
Giannini, C. Santoro, N. Caprio, S.et.al. The triglyserida to HDL cholesterol
ratio. Diabetes Care, volume 34 :1869 – 1874.
Gurung, A. Shivsekhar, M. 2013. Study of insulin resistanse and lipid profile
in obese adults : International Journal of Science Innovation and
Discoveries. 3 : 362-366.
Halim ,S.L. Iskandar, I. Edward, H. 2011. Kimia Klinik, Fakultas Kedokteran.
UKRIDA. Jakarta. p.10.
Hancox, R.J.2011. Corelation between measure of insulin resistance in
fasting and non fasting blood. Diabetology and Metabolic Syndrome.
3:23.
Haris , S. dan Tambunan, T.2009. Hipertensi Pada Sindroma Metabolik. Sari
Pediatri. 11(4) : 257-264.
Hassan, E.N. and. El-Masry, S.A. Obesity Degree and Cardiometabolic Risk
among Scholl Students. Life Science Journal; 9 (3). P. 293 – 301.
Universitas Sumatera Utara
64
He, J.2014. The TG/HDL-C Ratio Might Be a Surrogate for Insulin Resistance
Chinese Non obese Women. International Journal of Endocrinology. P.
1-7.
Hermanto, T.J., Sony, W. Banjarnahor, D.P.P. 2012. Korelasi antara HOMAIR Ibu Diabetes Mellitus Gestasional Trimester Tiga dengan Luaran
Maternal dan Neonatal. Majalah Obstetri & Ginekologi. 20(3) : 122126
Huguette,Y.M.2010.Prevalenceof insulin resistance in obese Cameroonian
Women. Journal of Diabetes and Endocrinology. vol. 1. pp. 19–26.
Imanuel, S. 2013. Patogenesis dan diagnosis laboratorik pradiabetik.
Departemen
Patologi
Klinik
Fakultas
Kedokteran
Universitas
Indonesia. Pendidikan Kedokteran Berkelanjutan Patologi Klinik.
pp.15.
Jafar, N. 2012. Sindroma Metabolik dan Epidemiologi : Media Gizi
Masyarakat Indonesia.1(2):71-78.
Jung, C.H 2010. The Relationship of Adiponectin/Leptin Ratio with
Homeostasis Model Assessment Insulin Resistance Index and
Metabolic Syndrome in Apparently Healthy Korean Male Adults.
Korean Diabetes J 2010;34:237-243.
Kahn, C.R. and Madson C.R. 2012. Tissue Spesific Insulin Signaling,
Metabolic Syndrome and Cardiovasculer
Disease : Arteriosclerose
Thrombosis Vascular Biologi. 32 : 2052-20591.
Universitas Sumatera Utara
65
Kumar, A. Singh, V.2010. Atherogenic dyslipidemia and diabetes mellitus:
what’s new in the management arena?. Vascular Health and Risk
Management . 6 :665-669
Kaur. J. 2014. A Comphrehensive Review on Metabolic Syndrome : Review
Article. Cardiology Research and Practice. Hindawi Publishing
Corporation. 31.pp.21.
Kawamoto, R. Tabara, Y. Kohara, K. et.al. 2011. Relation between lipid
profile and metabolic syndrome, insulin resistance and serum high
molecular adiponectin in Japanese community-dwelling adults : Lipid in
Health and Disease. 10:79
Kawamoto,
R.
Kohara,
K.
aminotransferase/aspartate
Kusunoki,T.,
et.al.
aminotransferase
2012.
ratio
is
Alanine
the
best
surrogate makrker insulin resistance in non obese Japanese adults.
Cardiovascular Diabetology. 11:117.
Kimm, H. Lee, S.W. Lee H.S. Shim, K.W. 2010. Association Between Lipid
Measure
and
Metabolic
Syndrome,
Insulin
Resistance
and
Adiponectin. Circulation Journal. Vol.74. p 931-937.
Krenzt, A.J and Wong N.D. 2007. Metabolic Syndrome and Kardiovascular
Disease.Epidemiology, Assesement and Management. Taylor and
Francis, New York . p 109 - 143
Universitas Sumatera Utara
66
Ku,
B.J.
2009.
Serum
ferritin
is
inversely
correlated
with
serum adiponectin level: Population-based cross-sectional study.
Disease Markers .Vol 27. 303–310
Kurzmarski, R.J. Flegal, K.M. 2000. Criteria for definition of overweight in
transition : background and recommendation for the United States. The
american Journal of clinical nutrition. 72 : 1074 – 81.
Lee, S.R. Cha, M.J. Kang, D.Y.et. al. 2011. Increased prevalence of
metabolic syndrome among hypertension population. International
Journal of Cardiology. Volume 166. Issue 3. p 633 – 639.
Lee, U.P. 2007. Insulin, lipid profiles and measures of fatness in
Taiwanese
women
in
relation
to
duration
of
residence
in
Australia. Asia Pac J Clin Nutr :16 (2):254-261
Leslie, B. 2005. Metabolic Syndrome. Historical Perspective. The American
Journal of Medical Science. 330 (6)p. 264 – 268.
Lwanga, S.K. and Lemeshow, S. 2004Sample size determination in health
studies. World Health Organization. Geneva.
Madsen, C.R. 2012. Tissue Spesific Insulin Signaling, Metabolic Syndrome
and CVD. Thromb Vasc Biol. 32(9): 2052-2059
Manju, C. Phillips, S. Ciaraldi, T. et.al. 2003. Adiponectin : more than just
another fat cell hormone? Diabetes Care . 26(8) : 2442 – 50
Universitas Sumatera Utara
67
Marjani,A. 2011. Waist Circumference, Body Mass Index, Hip Circumference
and Waist-To-Hip Ratioin type 2 diabetes patients in Gorgan, Iran.
Journal of Clinical and Diagnostic Research. Vol-5(2):201-205
Mashabi, Y. 2013. Penilaian ratio Apo B/Apo A pada subjek sindroma
metabolik dan obesitas, Tesis. Program Magister Klinik – Spesialis
Patologi Klinik. Fakultas Kedokteran Universitas Sumatera Utara –
Rumah Sakit Umum Pusat Haji Adam Malik. pp.25
McLaughlin, T. Use of metabolic markers to identify overweight individuals
who are insulin resistant. Annals of Internal Medicine. vol. 139. no. 10,
pp. 802–809.
Merentek, E., 2006, Resistensi Insulin Pada Diabetes Mellitus Tipe 2, Cermin
Dunia Kedokteran, No 150, 39-41, Poliklinik Endrokrin Metabolik,
Bagian Penyakit Dalam Rumah Sakit Umum Gowa, Makasar.
Meshkani, R. Adeli, K. 2009. Mechanism linking the metabolic syndrome and
cardiovascular disease : role of hepatic insulin resistance. The journal
of Tehran Univlersityl Hearth Center, pp. 77 – 83.
Mittal, S. 2008. The metabolic syndrome in clinical practice, Spinger –Verlag,
London. pp.40.
Mukherjee B, Hossain C.M., Mondal, L., Paul, P.,et.al. (2013). Obesity and
insulin resistance: an abridged molecular correlation. Lipid Insights 6 :
1–11.
Universitas Sumatera Utara
68
Mohiuddin, S.M. 2013. The Association Between Serum Lipid Ratio and
Insulin Resistance Among Subject with Impaired Glucose Tolerance in
Pakistan. University of Oslo Institue of
Health and Society.
Departemen of Community Medicine,Pakistan.Thesis.p.43.
Momin, A.A. Bankar, M.P. Bhoite, G.M. 2014. Determination of HOMA IR cut
off value, and efficiency of lipids and lipoprotein ratios as discriminator
of insulin resistance in type 2 Diabetes Mellitus patients. Journal Of
Pharmacy. Vol 4. Issue 6. Pp09-14.
Mostafa, S.A. 2012. The Association of the Triglyceride-to-HDL Cholesterol
Ratio with Insulin Resistance in White Europe and South Asian Men
and Women. PlosOne.7(12).P.1-7
Olivia, A.2011. Examining the Association Between Body Mass Index and
Weight Related Quality of Life in Black and White Women. Quality of
Life Journal. Volume 7. Issue 3. Pp 309 – 322.
Olson, K. 2012. The Triglyceride to HDL Ratio And its Relatonship to Insulin
Resitance in Pre –and Postpubertal Children : Observation from the
Wasau
SCHOOL
Project.
Hindawi
Publishing
Corporation
Cholesterol.p1-4.
Pereira, T. 2012. Dyslipidemia and cardiovascular risk : lipid ratio as risk
factor for cardiovascular disease. College of Health Technologies,
Polytechnic nstitute of Coimbra Portugal. Intech p.280 – 302.
Universitas Sumatera Utara
69
Pitocco, D., Tesauro, M., Allesandro, R., et.al. 2013. Oxidative stress in
diabetes : implication for valscular other implication. International
Journal of Molecular Science. 14 : 21525 – 21550.
Polyana, R.S. 2015. Correlation of Insulin Resistance with Anthropometric
Measures and Blood Pressure in Adolescents. Arq Bras Cardiol. P .1-8
Pownall, H.J. and Gotto, A.M. 2009. Human Plasma Lipoprotein : In Clinical
lipidology a companion to Braunwald’s hearth disease. Ballantyne,
C.M.ed. Philadelphia, 1st ed. Elsiver. pp. 1-5.
Radikova,
Z.2003.
Assessment
of
Insulin
Sensitivity/Resistance
in
Epidemilogical. Endocrine Regulation. 37:189-194.
Ray, S. Talukadar, A. Sonthalia , N. et.al. 2015 Serum lipoprotein ratio as
marker of insulin resistance : A study among non-diabetic acute
coronoray syndrome patient with impaired fasting glucose. Indian
Journal Medical Research. 141 : 62-67.
Redon, J. Cifkova ,R.Laurent ,S.
et.al. The metabolic syndrome in
hypertension: European society of hypertension position statement.
Journal of Hypertension 2008, 26:1891–1900
Riset Kesehatan Dasar 2013. Badan penelitian dan pengembangan
kesehatan. Kementerian Kesehatan Republik Indonesia. p.16.
Shanta, G.P.S. Kumar, A.A. Kahan, S. 2013. Triglyceride/HDL Ratio as a
Screening Tool for Predicting. Triglyceride/HDL Ratio and Diabetes
Medications. July 2013. Volume 8 . Issue 7. p 1 – 6.
Universitas Sumatera Utara
70
Sharma, J. Khare, S. Shrivastavia S.,Kaira, S. 2011. Etiology of obesity : what
a family practitioner needs to know. Research of diabetes and
endocrinologly. webmed central . pp.1-9
Shentil. 2012. Association between liver insulin resistance and cardiovascular
risk factors.The Association for the Publication of the Journal of
Internal Medicine 403. Journal of Internal Medicine. 272: 402–408.
Shinsha, S. and Akhter, Q.S. 2015. Correlation Study of Insulin Resistance
and Essential Hypertension among Bangladeshi Male Volunteers.
Journal of Young Pharmacists .7(3) .p.201-205
Shood, R.2006. The Endocryne System in Textbook of Medical Laboratory.
Medical Publisher. P.585
Silalahi, T. 2013. Perbedaan kadar hs-CRP pada subjek obesitas
metabolik dan
non sindrom
sindrom
metabolik. Tesis,. Program Magister
Klinik – Spesialis Patologi Klinik, Fakultas Kedokteran Universitas
Sumatera Utara – Rumah Sakit Umum Pusat Haji Adam Malik. pp.31.
Simanjuntak, Z. 2013. Hubungan serum ferritin dengan resistensi insulin yang
dihubungkan dengan HOMA-IR pada penderita sindroma metabolik.
Tesis. Program Magister Klinik – Spesialis Patologi Klinik, Fakultas
Kedokteran Universitas Sumatera Utara – Rumah Sakit Umum Pusat
Haji Adam Malik.pp. 17.
Sudoyo, A.W.2009. Buku Ajar Ilmu Penyakit Dalam Jilid II edisi V. Jakarta:
Interna Publishing 2.
Universitas Sumatera Utara
71
Sumner,
A.E.
2005.
Fasting
triglyceride
and
the
triglyceride-HDL
cholesterol ratio are not markers of insulin resistance in African
Americans, Archives of Internal Medicine, vol. 165, no. 12, pp.
1395–1400.
Soegondo, S. 2001. Atherogenic dyslipidemia and the metabolic syndrome
clinical
practice.
Arta
medical
indonesia
–
Indonesia
Jurnal
Internasional Medikal. 37 : 177 – 183.
Soh, J. Josekutty, J. Hussain, M.M. 2011. Lipid and dyslipoproteinemia : In
Henry’s clinical diagnosis and management by laboratory methods.
Mc.Pherson, R.A., & Pincus, M.R.ed. Philadelphia, 22 nd ed, Elsevier.
p.226.
Sulistyoningrum. 2010. Tinjauan molekuler dan aspek klinis resistensi insulin.
Fakultas Kedokteran dan Ilmu kesehatan. Universitas Jenderal
Soedirman. Mandala of health journal . 2 :131-138
Tabata, S. 2009. Waist circumference and insulin resistance : a crosssectional study of Japanese men. BMC Endocrine Disorder. Vol
10.1186/1472-6823-9-1.
Umboh, A. 2007. Hubungan Antara Resistensi Insulin dan Tekanan Darah
Pada Anak Obese. Sari Pediatri. Vol 8. No 4. P 289 – 293.
Vangaripu, J. 2012. Association between liver insulin resistance and
cardiovascular risk factors.The Association for the Publication of the
Universitas Sumatera Utara
72
Journal of Internal Medicine 403. Journal of Internal Medicine. 272:
402–408.
Vigil,L and Goday. A. 2011. Metabolic syndrome and insulin resistance are
associated with Chronic Kidney Disease in Non Diabetic with
Abdominal Obesity. International journal of clinical medicine. 2011. 367
– 377.
Wallace, T.M. Levy J.C.. and Matthew D.R.2004. Use and Abuse of HOMA
Modelling. Diabetes Care. 27: 1487 – 1495.
Waist circumference and waist hip ratio. 2008.
Report of a WHO expert
consultation. Geneva, pp.8.
Wilcox, G. 2005. Insulin and Insulin Resistance. Clinical Biochemistry
Review.; 26(2): 19 – 39.
Yoon, H. and Jeon, J.D. 2016. Relationship between homeostasis model
assessment of insulin resistance and beta cell function and serum 25hydroxyvitamin D in non-diabetic Korean adults. J.Clin. Biochem.
Nutr.p 1 – 6.
Zhang, L. Chen S. Deng, A.,et.al. 2015 Association between Lipid Ratio and
Insulin Resistance in a Chinese Population : Serum Lipids Ratios and
Insulin . Journal pone. pp. 1-13.
Universitas Sumatera Utara
DAFTAR PUSTAKA
Abboth, 2006. Glucose. Clinical Chemistry. Architec-Aeroseth. Abboth
Diagnostic. p 1-8
Abboth, 2006. Cholesterol. Clinical Chemistry. Architec-Aeroseth. Abboth
Diagnostic. p 1-12
Abboth, 2007. Triglyseride. Clinical Chemistry. Architec-Aeroseth. Abboth
Diagnostic. p 1-9
Abboth, 2008. UHDL. Clinical Chemistry. Architec-Aeroseth. Abboth
Diagnostic. p 1-9
Adekune,
A.E.
Akande,
Syndrome:Prevalence
A.O.
Adekunle,
A.O.
2014.
Metabolic
and Association with Electrocardiographic
Abnormalities in Nigerian Hypertensive Patients.Vol : 12(8) : 447 –
442.
Anwar, T.B. 2004. Dislipidemia sebagai factor resiko Penyakit Jantung
Koroner. Fakultas Kedokteran . e-Universitas Sumatera Utara. p.2.
Atkinson, R. 2004. Etiology of obesity : In The management of eating disorder
and obesity. Goldstein, J.D.ed. 2nd ed, New Jersey. Human Press Inc.
pp.105.
Ascaso, J.F. Pardo, S. Real, J.T. et.al. 2003. Diagnosis insulin resistance by
simple quantitative methods in subjects with normal glucose
metabolism. Diabetes care. 26 : 3320 – 3325.
Universitas Sumatera Utara
61
Aquilante,
C.L.
and
Griend
J.P.
V.2012.
Metabolic
syndrome.
Pharmacotherapy Self-Assessment Program. 6th Ed. 109 – 115.
Balai Penelitian dan Pengembangan Kesehatan , 2007. Depkes RI. Pedoman
Pengukuran dan Pemeriksaan. Riset Kesehatan Dasar.
Bakker, S.J. Gans, R. Maaten, J.C. 2001.The Potential Role of Adenosine in
The
Pathophysiology
of
The
Insulin
Resistance
Syndrome.
Atherosclerosis 2001. 156: 283 – 290.
Bosomworth, N.J.2013. Approach to identifying and managing atherogenic
dyslipidemia. Canadian Family Physician. Vol 59: 1169 -1180.
Brunzel, J.D. 2009. Genetic Dyslipidemia In : Clinical Lipidology .
Christie,M.ed. Saunders Elsevier. 1st ed. pp 71-80.
Byrne, C.D. 2005. The Global Burden of the Metabolic Syndrome and its
Consequencea for Diabetes and Cardiovascular. Dalam : Metabolic
Syndrome. England. Byrne, C.D. and Wild, S.W.ed. John Wiley & Sons
Ltd. pp. 1.
Byun, A.R. Wha S.L. Lee, H.S. Shim, K.W. 2015. What is the most
appropriate lipid profile ratio predictor for insulin resistance in each
sex? A cross sectional study in Korean populations (the fifth korea
national health and nutrition examination survey. Diabetology and
metabolic syndrome .7:59.
Universitas Sumatera Utara
62
Cerelio, A .2005. Oxidate stress, insulin resistance and cardiovascular
disease : In Metabolic Syndrome. Byrne, C.D. England : John Wiley &
Sons Ltd, pp. 191-190.
Chaves, A.G. Mendia, L.E.S. Argueta, S.E. 2011. Elevated triglycerides/HDL
cholesterol associated with insulin resistance. Cirugia y Cirujanos . 79
:115 – 119.
Cornier, M.A. Dabelea , D. Hernandez T.L. et.al. 2008. The metabolic
Syndrome : Endocrine Review. 29(7) :777 – 822.
Chu, M.A.2011. HOMA-IR and Its Association with Metabolic Risk Factors
among Korean Adolescent. Korean J Gastroenterolog Nutric.14(4):
376 -384
Davis, P.G. 2006. Lipid and lipoprotein metabolism. In : Lipid metabolism and
health. Moffat, R.J., Stamford, B. ed. United States of Taylor : Taylor &
Francis Group. p. 47-50.
Du, T.
Yuan,G. Zhang, M. et.al.2014. Clinical usefulness of lipid ratios,
visceral adiposity indicators, and the triglycerides and glucose index as
risk markers of insulin resistance. Cardiovascular Diabetology. :134.
p1-10.
Dupon, J.L. 2006. Basic Lipidogy In : Lipid Metabolism and Health. Moffatt,
J.R., Stamford, B. Taylor & Francis Group. United States of America.
p.13-17.
Universitas Sumatera Utara
63
Ezra, V.B.(2006)
Metabolic Syndrome In : Lipid metabolism and health.
Moffat, R.J., Stamford, B. ed. United States of Taylor : Taylor & Francis
Group. p. 47-50.
Gerich, J.E. Dodis, R. 2007. Glycemic control and the metabolic syndrome :
In Metabolic syndrome and cardiovascular, epidemiology, assesement
and management. Krentz, A.J.ed. United State of America. Informa
health care USA Inc, pp.145-155.
Giannini, C. Santoro, N. Caprio, S.et.al. The triglyserida to HDL cholesterol
ratio. Diabetes Care, volume 34 :1869 – 1874.
Gurung, A. Shivsekhar, M. 2013. Study of insulin resistanse and lipid profile
in obese adults : International Journal of Science Innovation and
Discoveries. 3 : 362-366.
Halim ,S.L. Iskandar, I. Edward, H. 2011. Kimia Klinik, Fakultas Kedokteran.
UKRIDA. Jakarta. p.10.
Hancox, R.J.2011. Corelation between measure of insulin resistance in
fasting and non fasting blood. Diabetology and Metabolic Syndrome.
3:23.
Haris , S. dan Tambunan, T.2009. Hipertensi Pada Sindroma Metabolik. Sari
Pediatri. 11(4) : 257-264.
Hassan, E.N. and. El-Masry, S.A. Obesity Degree and Cardiometabolic Risk
among Scholl Students. Life Science Journal; 9 (3). P. 293 – 301.
Universitas Sumatera Utara
64
He, J.2014. The TG/HDL-C Ratio Might Be a Surrogate for Insulin Resistance
Chinese Non obese Women. International Journal of Endocrinology. P.
1-7.
Hermanto, T.J., Sony, W. Banjarnahor, D.P.P. 2012. Korelasi antara HOMAIR Ibu Diabetes Mellitus Gestasional Trimester Tiga dengan Luaran
Maternal dan Neonatal. Majalah Obstetri & Ginekologi. 20(3) : 122126
Huguette,Y.M.2010.Prevalenceof insulin resistance in obese Cameroonian
Women. Journal of Diabetes and Endocrinology. vol. 1. pp. 19–26.
Imanuel, S. 2013. Patogenesis dan diagnosis laboratorik pradiabetik.
Departemen
Patologi
Klinik
Fakultas
Kedokteran
Universitas
Indonesia. Pendidikan Kedokteran Berkelanjutan Patologi Klinik.
pp.15.
Jafar, N. 2012. Sindroma Metabolik dan Epidemiologi : Media Gizi
Masyarakat Indonesia.1(2):71-78.
Jung, C.H 2010. The Relationship of Adiponectin/Leptin Ratio with
Homeostasis Model Assessment Insulin Resistance Index and
Metabolic Syndrome in Apparently Healthy Korean Male Adults.
Korean Diabetes J 2010;34:237-243.
Kahn, C.R. and Madson C.R. 2012. Tissue Spesific Insulin Signaling,
Metabolic Syndrome and Cardiovasculer
Disease : Arteriosclerose
Thrombosis Vascular Biologi. 32 : 2052-20591.
Universitas Sumatera Utara
65
Kumar, A. Singh, V.2010. Atherogenic dyslipidemia and diabetes mellitus:
what’s new in the management arena?. Vascular Health and Risk
Management . 6 :665-669
Kaur. J. 2014. A Comphrehensive Review on Metabolic Syndrome : Review
Article. Cardiology Research and Practice. Hindawi Publishing
Corporation. 31.pp.21.
Kawamoto, R. Tabara, Y. Kohara, K. et.al. 2011. Relation between lipid
profile and metabolic syndrome, insulin resistance and serum high
molecular adiponectin in Japanese community-dwelling adults : Lipid in
Health and Disease. 10:79
Kawamoto,
R.
Kohara,
K.
aminotransferase/aspartate
Kusunoki,T.,
et.al.
aminotransferase
2012.
ratio
is
Alanine
the
best
surrogate makrker insulin resistance in non obese Japanese adults.
Cardiovascular Diabetology. 11:117.
Kimm, H. Lee, S.W. Lee H.S. Shim, K.W. 2010. Association Between Lipid
Measure
and
Metabolic
Syndrome,
Insulin
Resistance
and
Adiponectin. Circulation Journal. Vol.74. p 931-937.
Krenzt, A.J and Wong N.D. 2007. Metabolic Syndrome and Kardiovascular
Disease.Epidemiology, Assesement and Management. Taylor and
Francis, New York . p 109 - 143
Universitas Sumatera Utara
66
Ku,
B.J.
2009.
Serum
ferritin
is
inversely
correlated
with
serum adiponectin level: Population-based cross-sectional study.
Disease Markers .Vol 27. 303–310
Kurzmarski, R.J. Flegal, K.M. 2000. Criteria for definition of overweight in
transition : background and recommendation for the United States. The
american Journal of clinical nutrition. 72 : 1074 – 81.
Lee, S.R. Cha, M.J. Kang, D.Y.et. al. 2011. Increased prevalence of
metabolic syndrome among hypertension population. International
Journal of Cardiology. Volume 166. Issue 3. p 633 – 639.
Lee, U.P. 2007. Insulin, lipid profiles and measures of fatness in
Taiwanese
women
in
relation
to
duration
of
residence
in
Australia. Asia Pac J Clin Nutr :16 (2):254-261
Leslie, B. 2005. Metabolic Syndrome. Historical Perspective. The American
Journal of Medical Science. 330 (6)p. 264 – 268.
Lwanga, S.K. and Lemeshow, S. 2004Sample size determination in health
studies. World Health Organization. Geneva.
Madsen, C.R. 2012. Tissue Spesific Insulin Signaling, Metabolic Syndrome
and CVD. Thromb Vasc Biol. 32(9): 2052-2059
Manju, C. Phillips, S. Ciaraldi, T. et.al. 2003. Adiponectin : more than just
another fat cell hormone? Diabetes Care . 26(8) : 2442 – 50
Universitas Sumatera Utara
67
Marjani,A. 2011. Waist Circumference, Body Mass Index, Hip Circumference
and Waist-To-Hip Ratioin type 2 diabetes patients in Gorgan, Iran.
Journal of Clinical and Diagnostic Research. Vol-5(2):201-205
Mashabi, Y. 2013. Penilaian ratio Apo B/Apo A pada subjek sindroma
metabolik dan obesitas, Tesis. Program Magister Klinik – Spesialis
Patologi Klinik. Fakultas Kedokteran Universitas Sumatera Utara –
Rumah Sakit Umum Pusat Haji Adam Malik. pp.25
McLaughlin, T. Use of metabolic markers to identify overweight individuals
who are insulin resistant. Annals of Internal Medicine. vol. 139. no. 10,
pp. 802–809.
Merentek, E., 2006, Resistensi Insulin Pada Diabetes Mellitus Tipe 2, Cermin
Dunia Kedokteran, No 150, 39-41, Poliklinik Endrokrin Metabolik,
Bagian Penyakit Dalam Rumah Sakit Umum Gowa, Makasar.
Meshkani, R. Adeli, K. 2009. Mechanism linking the metabolic syndrome and
cardiovascular disease : role of hepatic insulin resistance. The journal
of Tehran Univlersityl Hearth Center, pp. 77 – 83.
Mittal, S. 2008. The metabolic syndrome in clinical practice, Spinger –Verlag,
London. pp.40.
Mukherjee B, Hossain C.M., Mondal, L., Paul, P.,et.al. (2013). Obesity and
insulin resistance: an abridged molecular correlation. Lipid Insights 6 :
1–11.
Universitas Sumatera Utara
68
Mohiuddin, S.M. 2013. The Association Between Serum Lipid Ratio and
Insulin Resistance Among Subject with Impaired Glucose Tolerance in
Pakistan. University of Oslo Institue of
Health and Society.
Departemen of Community Medicine,Pakistan.Thesis.p.43.
Momin, A.A. Bankar, M.P. Bhoite, G.M. 2014. Determination of HOMA IR cut
off value, and efficiency of lipids and lipoprotein ratios as discriminator
of insulin resistance in type 2 Diabetes Mellitus patients. Journal Of
Pharmacy. Vol 4. Issue 6. Pp09-14.
Mostafa, S.A. 2012. The Association of the Triglyceride-to-HDL Cholesterol
Ratio with Insulin Resistance in White Europe and South Asian Men
and Women. PlosOne.7(12).P.1-7
Olivia, A.2011. Examining the Association Between Body Mass Index and
Weight Related Quality of Life in Black and White Women. Quality of
Life Journal. Volume 7. Issue 3. Pp 309 – 322.
Olson, K. 2012. The Triglyceride to HDL Ratio And its Relatonship to Insulin
Resitance in Pre –and Postpubertal Children : Observation from the
Wasau
SCHOOL
Project.
Hindawi
Publishing
Corporation
Cholesterol.p1-4.
Pereira, T. 2012. Dyslipidemia and cardiovascular risk : lipid ratio as risk
factor for cardiovascular disease. College of Health Technologies,
Polytechnic nstitute of Coimbra Portugal. Intech p.280 – 302.
Universitas Sumatera Utara
69
Pitocco, D., Tesauro, M., Allesandro, R., et.al. 2013. Oxidative stress in
diabetes : implication for valscular other implication. International
Journal of Molecular Science. 14 : 21525 – 21550.
Polyana, R.S. 2015. Correlation of Insulin Resistance with Anthropometric
Measures and Blood Pressure in Adolescents. Arq Bras Cardiol. P .1-8
Pownall, H.J. and Gotto, A.M. 2009. Human Plasma Lipoprotein : In Clinical
lipidology a companion to Braunwald’s hearth disease. Ballantyne,
C.M.ed. Philadelphia, 1st ed. Elsiver. pp. 1-5.
Radikova,
Z.2003.
Assessment
of
Insulin
Sensitivity/Resistance
in
Epidemilogical. Endocrine Regulation. 37:189-194.
Ray, S. Talukadar, A. Sonthalia , N. et.al. 2015 Serum lipoprotein ratio as
marker of insulin resistance : A study among non-diabetic acute
coronoray syndrome patient with impaired fasting glucose. Indian
Journal Medical Research. 141 : 62-67.
Redon, J. Cifkova ,R.Laurent ,S.
et.al. The metabolic syndrome in
hypertension: European society of hypertension position statement.
Journal of Hypertension 2008, 26:1891–1900
Riset Kesehatan Dasar 2013. Badan penelitian dan pengembangan
kesehatan. Kementerian Kesehatan Republik Indonesia. p.16.
Shanta, G.P.S. Kumar, A.A. Kahan, S. 2013. Triglyceride/HDL Ratio as a
Screening Tool for Predicting. Triglyceride/HDL Ratio and Diabetes
Medications. July 2013. Volume 8 . Issue 7. p 1 – 6.
Universitas Sumatera Utara
70
Sharma, J. Khare, S. Shrivastavia S.,Kaira, S. 2011. Etiology of obesity : what
a family practitioner needs to know. Research of diabetes and
endocrinologly. webmed central . pp.1-9
Shentil. 2012. Association between liver insulin resistance and cardiovascular
risk factors.The Association for the Publication of the Journal of
Internal Medicine 403. Journal of Internal Medicine. 272: 402–408.
Shinsha, S. and Akhter, Q.S. 2015. Correlation Study of Insulin Resistance
and Essential Hypertension among Bangladeshi Male Volunteers.
Journal of Young Pharmacists .7(3) .p.201-205
Shood, R.2006. The Endocryne System in Textbook of Medical Laboratory.
Medical Publisher. P.585
Silalahi, T. 2013. Perbedaan kadar hs-CRP pada subjek obesitas
metabolik dan
non sindrom
sindrom
metabolik. Tesis,. Program Magister
Klinik – Spesialis Patologi Klinik, Fakultas Kedokteran Universitas
Sumatera Utara – Rumah Sakit Umum Pusat Haji Adam Malik. pp.31.
Simanjuntak, Z. 2013. Hubungan serum ferritin dengan resistensi insulin yang
dihubungkan dengan HOMA-IR pada penderita sindroma metabolik.
Tesis. Program Magister Klinik – Spesialis Patologi Klinik, Fakultas
Kedokteran Universitas Sumatera Utara – Rumah Sakit Umum Pusat
Haji Adam Malik.pp. 17.
Sudoyo, A.W.2009. Buku Ajar Ilmu Penyakit Dalam Jilid II edisi V. Jakarta:
Interna Publishing 2.
Universitas Sumatera Utara
71
Sumner,
A.E.
2005.
Fasting
triglyceride
and
the
triglyceride-HDL
cholesterol ratio are not markers of insulin resistance in African
Americans, Archives of Internal Medicine, vol. 165, no. 12, pp.
1395–1400.
Soegondo, S. 2001. Atherogenic dyslipidemia and the metabolic syndrome
clinical
practice.
Arta
medical
indonesia
–
Indonesia
Jurnal
Internasional Medikal. 37 : 177 – 183.
Soh, J. Josekutty, J. Hussain, M.M. 2011. Lipid and dyslipoproteinemia : In
Henry’s clinical diagnosis and management by laboratory methods.
Mc.Pherson, R.A., & Pincus, M.R.ed. Philadelphia, 22 nd ed, Elsevier.
p.226.
Sulistyoningrum. 2010. Tinjauan molekuler dan aspek klinis resistensi insulin.
Fakultas Kedokteran dan Ilmu kesehatan. Universitas Jenderal
Soedirman. Mandala of health journal . 2 :131-138
Tabata, S. 2009. Waist circumference and insulin resistance : a crosssectional study of Japanese men. BMC Endocrine Disorder. Vol
10.1186/1472-6823-9-1.
Umboh, A. 2007. Hubungan Antara Resistensi Insulin dan Tekanan Darah
Pada Anak Obese. Sari Pediatri. Vol 8. No 4. P 289 – 293.
Vangaripu, J. 2012. Association between liver insulin resistance and
cardiovascular risk factors.The Association for the Publication of the
Universitas Sumatera Utara
72
Journal of Internal Medicine 403. Journal of Internal Medicine. 272:
402–408.
Vigil,L and Goday. A. 2011. Metabolic syndrome and insulin resistance are
associated with Chronic Kidney Disease in Non Diabetic with
Abdominal Obesity. International journal of clinical medicine. 2011. 367
– 377.
Wallace, T.M. Levy J.C.. and Matthew D.R.2004. Use and Abuse of HOMA
Modelling. Diabetes Care. 27: 1487 – 1495.
Waist circumference and waist hip ratio. 2008.
Report of a WHO expert
consultation. Geneva, pp.8.
Wilcox, G. 2005. Insulin and Insulin Resistance. Clinical Biochemistry
Review.; 26(2): 19 – 39.
Yoon, H. and Jeon, J.D. 2016. Relationship between homeostasis model
assessment of insulin resistance and beta cell function and serum 25hydroxyvitamin D in non-diabetic Korean adults. J.Clin. Biochem.
Nutr.p 1 – 6.
Zhang, L. Chen S. Deng, A.,et.al. 2015 Association between Lipid Ratio and
Insulin Resistance in a Chinese Population : Serum Lipids Ratios and
Insulin . Journal pone. pp. 1-13.
Universitas Sumatera Utara